Malignant disease assessment and prognosis encompasses the diagnostic evaluation, staging, and prediction of clinical outcomes for patients with cancer and hematologic malignancies. Research published in Hematology and Oncology Research addresses multiple dimensions of this field, including the identification of nov…
Malignant disease assessment and prognosis encompasses the diagnostic evaluation, staging, and prediction of clinical outcomes for patients with cancer and hematologic malignancies. Research published in Hematology and Oncology Research addresses multiple dimensions of this field, including the identification of novel biomarkers to improve diagnostic accuracy in challenging malignancies such as uterine leiomyosarcoma, and the refinement of imaging techniques for precise target volume definition in treating atypical meningiomas with radiosurgery. The journal has examined metabolic pathways as potential therapeutic targets in chronic lymphocytic leukemia, recognizing that understanding tumor biology informs both prognosis and treatment strategies. Diagnostic cytology studies have explored the clinical significance of atypical or suspicious findings in lymphoid lesions, addressing the challenges of accurate classification. Additional work has investigated hypercoagulability in acute leukemia patients, a complication with prognostic implications, and explored non-invasive screening approaches using biochemical markers for prostate cancer detection. The journal also documents clinical experiences with Hodgkin's lymphoma in resource-limited settings, highlighting how assessment and prognostic capabilities vary across different healthcare contexts. This body of work reflects the multifaceted nature of malignant disease evaluation, spanning molecular markers, imaging modalities, laboratory findings, and clinical outcomes across diverse cancer types.
7 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 7 articles above have been cited 79 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Malignant Disease Assessment and Prognosis, linking to each citing work.